Congress Demands Answers on Data Privacy Ahead of 23andMe Sale

As the genetic testing company 23andMe prepares for a potential sale, Congress is demanding answers on how the company plans to protect the data privacy of its customers.

Lawmakers are concerned about the sensitive genetic information collected by 23andMe and how it could be used or sold in the future.

With data privacy becoming a growing concern in the digital age, Congress is taking steps to ensure that companies like 23andMe are held accountable for protecting the personal information of their users.

The sale of 23andMe could have significant implications for the future of genetic testing and data privacy regulations.

Lawmakers are pushing for transparency and accountability from 23andMe to ensure that the privacy of individuals’ genetic data is safeguarded.

The debate over data privacy and genetic testing is expected to continue as technology advances and companies like 23andMe become increasingly popular.

Congress is expected to hold hearings and gather testimony from experts in the field of data privacy and genetic testing to better understand the risks and benefits of companies like 23andMe.

As the sale of 23andMe looms, lawmakers are under pressure to act quickly to address concerns about data privacy and protect the rights of consumers.

The outcome of this debate could have far-reaching implications for the future of genetic testing and data privacy regulations in the United States.

Stay tuned as Congress continues to demand answers on data privacy ahead of the potential sale of 23andMe.